K895881 is an FDA 510(k) clearance for the MOTIONSPECT. Classified as Column, Adsorption, Low Density, Lipoprotein (product code LXW), Class III - Premarket Approval.
Submitted by Baltimore Therapeutic Equipment Co. (Hanover, US). The FDA issued a Cleared decision on April 10, 1990 after a review of 187 days - an extended review cycle.
This device falls under the Gastroenterology & Urology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. High regulatory complexity profile. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Baltimore Therapeutic Equipment Co. devices